Quofenix 300 mg powder for concentrate for solution for infusion

Licence status
Authorised: 16/12/2019
Active substances
DELAFLOXACIN MEGLUMINE
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/19/1393/001
Licence holder
A. Menarini Industrie Farmaceutische Riunite S.r.l.

Product documents

Licence information

ATC code
J01MA Fluoroquinolones, J01MA23 delafloxacin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/12/2019